Related Experiment Videos
Cell therapy in children with Down syndrome: a retrospective study
D C Van Dyke1, D J Lang, S van Duyne
1Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City 52242.
Pediatrics
|January 1, 1990
Summary
Cell therapy for Down syndrome, using animal fetal cells, lacks scientific evidence. A study found no developmental or growth improvements in treated individuals compared to controls.
Area of Science:
- Pediatric Medicine
- Genetics
- Developmental Biology
Background:
- Cell therapy, involving lyophilized animal fetal cells, is promoted as a Down syndrome treatment.
- Claims include improvements in cognition, motor skills, and social behavior, despite lacking empirical support.
- This therapy is illegal in the United States.
Purpose of the Study:
- To evaluate the efficacy of cell therapy in individuals with Down syndrome.
- To investigate potential improvements in growth, motor, cognitive, and adaptive/social development.
Main Methods:
- A study of 190 subjects, with 21 receiving cell therapy.
- Comparison of the cell-treated group with a matched control group.
- Assessment of 18 variables across growth, motor, cognitive, and adaptive/social domains.
Main Results:
- No statistically significant differences were observed between the cell-treated and control groups.
- Developmental and growth variables showed no improvement following cell therapy.
- Findings do not support claims of enhanced functioning.
Conclusions:
- Current evidence does not support the use of cell therapy for Down syndrome.
- Further research is needed to address parental concerns and explore evidence-based interventions.
- The study highlights the importance of empirical data in therapeutic decision-making for Down syndrome.